Treatment of Spinocerebellar Ataxia with Mesenchymal Stem Cells: A Phase I/IIa Clinical Study
Ataxia is one of the most devastating symptoms of many neurodegenerative disorders. As of today, there is not any effective treatment to retard its progression. Mesenchymal stem cells (MSCs) have shown promise in treating neurodegenerative diseases. We hereby report the results of a phase I/IIa clin...
Main Authors: | Yun-An Tsai, Ren-Shyan Liu, Jiing-Feng Lirng, Bang-Hung Yang, Chin-Hao Chang, Yi-Chen Wang, Yu-Shan Wu, Jennifer Hui-Chun Ho, Oscar K. Lee, Bing-Wen Soong |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-03-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368916X694373 |
Similar Items
-
Radiological hints for differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia
by: Hung-Chieh Chen, et al.
Published: (2022-06-01) -
Impaired Efficiency and Resilience of Structural Network in Spinocerebellar Ataxia Type 3
by: Yu-Te Wu, et al.
Published: (2018-12-01) -
MRl and MRS hints for the differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia type II
by: Hung-Chieh Chen, et al.
Published: (2024-04-01) -
Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
by: Po-Shan Wang, et al.
Published: (2012-01-01) -
CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3
by: Shang-Ran Huang, et al.
Published: (2017-01-01)